within Pharmacolibrary.Drugs.ATC.R;

model R07AB03
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 5.833333333333333e-05,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0006,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R07AB03</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Pentetrazol (also known as pentylenetetrazol or Metrazol) is a central nervous system stimulant that was historically used as a circulatory and respiratory stimulant, and as a convulsant to treat certain psychiatric conditions through convulsive therapy. It is no longer approved or used in modern clinical practice due to safety concerns, particularly its high risk of inducing seizures.</p><h4>Pharmacokinetics</h4><p>No published human pharmacokinetic models or primary PK data identified for pentetrazol. Parameters estimated based on class properties and historical context.</p><h4>References</h4><ol><li><p>Zolkowska, D, et al., &amp; Rogawski, MA (2021). Intranasal Allopregnanolone Confers Rapid Seizure Protection: Evidence for Direct Nose-to-Brain Delivery. <i>Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics</i> 18(1) 544–555. DOI:<a href=\"https://doi.org/10.1007/s13311-020-00985-5\">10.1007/s13311-020-00985-5</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33405197/\">https://pubmed.ncbi.nlm.nih.gov/33405197</a></p></li><li><p>Pieróg, M, et al., &amp; Wlaź, P (2021). Effect of Ellagic Acid on Seizure Threshold in Two Acute Seizure Tests in Mice. <i>Molecules (Basel, Switzerland)</i> 26(16) –. DOI:<a href=\"https://doi.org/10.3390/molecules26164841\">10.3390/molecules26164841</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/34443428/\">https://pubmed.ncbi.nlm.nih.gov/34443428</a></p></li><li><p>Pieróg, M, et al., &amp; Wlaź, P (2023). Anticonvulsant Profile of Selected Medium-Chain Fatty Acids (MCFAs) Co-Administered with Metformin in Mice in Acute and Chronic Treatment. <i>Molecules (Basel, Switzerland)</i> 28(9) –. DOI:<a href=\"https://doi.org/10.3390/molecules28093810\">10.3390/molecules28093810</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/37175220/\">https://pubmed.ncbi.nlm.nih.gov/37175220</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R07AB03;
